Schedule 13G ownership disclosure

Y-MABS THERAPEUTICS INC

Common Stock, $0.0001 par value · CUSIP: 984241109

Event date: 2025-08-08

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Glazer Capital, LLC

    Shares: 2,654,700.00 · Class: 5.84%

  • Paul J. Glazer

    Shares: 2,654,700.00 · Class: 5.84%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001076809-25-000098
Form type
SCHEDULE 13G
Filer
GLAZER CAPITAL, LLC
CIK
CIK 1076809
Filed
Aug 15, 2025
Reporting period
Aug 08, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub